N-(3-Ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, 95%, 95%

cas: 936446-61-6 — zobacz wszystkie produkty o tym numerze CAS, także pod innymi nazwami

N-(3-Ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, 95%, 95% (CAS 936446-61-6) to odczynnik chemiczny dostępny w ofercie Chemat. Dostępne opakowania: 250mg, 1g. Oferty producentów: Chemat.

• 2D
• 3D

N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine (CAS 936446-61-6) to związek chemiczny o wzorze sumarycznym C24H26N4O3 i masie molowej 418.5 g/mol. Nazwa systematyczna IUPAC: N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine. InChIKey: WBKHQQZRHCECKK-UHFFFAOYSA-N.

Dane identyfikacyjne

Wzór sumaryczny	C24H26N4O3
Masa molowa	418.5 g/mol
Nazwa IUPAC	N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
InChIKey	WBKHQQZRHCECKK-UHFFFAOYSA-N
SMILES	COC1=C(C=C2C(=C1)N=CN=C2NC3=CC=CC(=C3)C#C)OCCCN4CCOCC4

Dane obliczone przez PubChem (NCBI)

Synonimy: N-(3-Ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine, 4-Quinazolinamine, N-(3-ethynylphenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-, N-(3-ethynylphenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine, EGFR Inhibitor NRC-2694, N-(3-Ethynylphenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine, N-(3-ethynylphenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine, WBKHQQZRHCECKK-UHFFFAOYSA-N, orb1307951, orb1940704

Izomery (ten sam wzór sumaryczny)

(4S)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-[(1-methylcyclopropyl)methoxy]-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4R)-4-(4-cyano-2-methoxyphenyl)-5-cyclopentyloxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4R)-4-(4-cyano-2-methoxyphenyl)-5-(cyclobutylmethoxy)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4S)-4-(4-cyano-2-methoxyphenyl)-5-(cyclobutylmethoxy)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4R)-4-(4-cyano-2-methoxyphenyl)-2,8-dimethyl-5-[(1-methylcyclopropyl)methoxy]-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4S)-4-(4-cyano-2-methoxyphenyl)-5-(2-cyclopropylethoxy)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4R)-4-(4-cyano-2-methoxyphenyl)-5-(2-cyclopropylethoxy)-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

(4S)-4-(4-cyano-2-methoxyphenyl)-5-cyclopentyloxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide C₂₄H₂₆N₄O₃

N-[4-methyl-3-[1-(1-methylimidazole-4-carbonyl)piperidin-4-yl]oxyphenyl]benzamide C₂₄H₂₆N₄O₃

2-[[1-[1-(4-methoxyphenyl)cyclopropanecarbonyl]piperidin-4-yl]amino]-3H-quinazolin-4-one C₂₄H₂₆N₄O₃

14-methoxy-9-[(4-methylpiperazin-1-yl)methyl]-9,19-diazapentacyclo[10.7.0.02,6.07,11.013,18]nonadeca-1(12),2(6),7(11),13(18),14,16-hexaene-8,10-dione C₂₄H₂₆N₄O₃

6-(2,3-dihydro-1H-inden-2-ylamino)-1-ethyl-3-(morpholine-4-carbonyl)-1,8-naphthyridin-4-one C₂₄H₂₆N₄O₃